<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	>

<channel>
	<title>PR Hub &#187; Infectious Disease Control</title>
	<atom:link href="http://pr.gaeatimes.com/c/health/infectious-disease-control/feed/" rel="self" type="application/rss+xml" />
	<link>http://pr.gaeatimes.com</link>
	<description></description>
	<pubDate>Tue, 13 Dec 2011 14:20:23 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.7.1</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Merck Serono Helps Eliminate Schistosomiasis in Africa</title>
		<link>http://pr.gaeatimes.com/merck-serono-helps-eliminate-schistosomiasis-in-africa-54730/</link>
		<comments>http://pr.gaeatimes.com/merck-serono-helps-eliminate-schistosomiasis-in-africa-54730/#comments</comments>
		<pubDate>Tue, 13 Dec 2011 05:00:00 +0000</pubDate>
		<dc:creator>Merck Serono S A</dc:creator>
		
		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Business]]></category>

		<category><![CDATA[Education]]></category>

		<category><![CDATA[Foreign Policy / International Affairs]]></category>

		<category><![CDATA[Government and Policy]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Infectious Disease Control]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[Not For Profit]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Africa]]></category>

		<category><![CDATA[December 13]]></category>

		<category><![CDATA[Geneva]]></category>

		<category><![CDATA[Merck Serono S A]]></category>

		<category><![CDATA[Switzerland]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/merck-serono-helps-eliminate-schistosomiasis-in-africa-54730/</guid>
		<description><![CDATA[GENEVA, December 13, 2011  -

Number of donated tablets doubled to around 50 million per year


Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced its intention to further boost its efforts in the fight against the tropical disease schistosomiasis and to continue until the disease has been officially eliminated in Africa. The company plans .... <a href="http://pr.gaeatimes.com/merck-serono-helps-eliminate-schistosomiasis-in-africa-54730/">Original article on Gaea Times at  &nbsp;: Merck Serono Helps Eliminate Schistosomiasis in Africa</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/merck-serono-helps-eliminate-schistosomiasis-in-africa-54730/feed/</wfw:commentRss>
		</item>
		<item>
		<title>African Leaders Malaria Alliance Applauds Decline in Malaria Deaths, Vows to Continue Progress</title>
		<link>http://pr.gaeatimes.com/african-leaders-malaria-alliance-applauds-decline-in-malaria-deaths-vows-to-continue-progress-54780/</link>
		<comments>http://pr.gaeatimes.com/african-leaders-malaria-alliance-applauds-decline-in-malaria-deaths-vows-to-continue-progress-54780/#comments</comments>
		<pubDate>Tue, 13 Dec 2011 05:00:00 +0000</pubDate>
		<dc:creator>African Leaders Malaria Alliance</dc:creator>
		
		<category><![CDATA[Foreign Policy / International Affairs]]></category>

		<category><![CDATA[Government and Policy]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Infectious Disease Control]]></category>

		<category><![CDATA[Africa]]></category>

		<category><![CDATA[African Leaders Malaria Alliance]]></category>

		<category><![CDATA[December 13]]></category>

		<category><![CDATA[New York]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/african-leaders-malaria-alliance-applauds-decline-in-malaria-deaths-vows-to-continue-progress-54780/</guid>
		<description><![CDATA[NEW YORK, December 13, 2011  -

The African Leaders Malaria Alliance (ALMA) applauds the progress announced today in the World Health Organization&#8217;s 2011 World Malaria Report, which finds a 26% drop in global malaria deaths since the year 2000, and a more than five percent drop in the past year.
Africa recorded an even larger reduction .... Read the original article &nbsp;: <a href="http://pr.gaeatimes.com/african-leaders-malaria-alliance-applauds-decline-in-malaria-deaths-vows-to-continue-progress-54780/">African Leaders Malaria Alliance Applauds Decline in Malaria Deaths, Vows to Continue Progress</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/african-leaders-malaria-alliance-applauds-decline-in-malaria-deaths-vows-to-continue-progress-54780/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Bringing Pain Management to Africa: Spreading Relief Through Training</title>
		<link>http://pr.gaeatimes.com/bringing-pain-management-to-africa-spreading-relief-through-training-54188/</link>
		<comments>http://pr.gaeatimes.com/bringing-pain-management-to-africa-spreading-relief-through-training-54188/#comments</comments>
		<pubDate>Thu, 01 Dec 2011 05:00:00 +0000</pubDate>
		<dc:creator>Fhssa</dc:creator>
		
		<category><![CDATA[Government and Policy]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Infectious Disease Control]]></category>

		<category><![CDATA[Not For Profit]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Alexandria]]></category>

		<category><![CDATA[December 1]]></category>

		<category><![CDATA[Fhssa]]></category>

		<category><![CDATA[virginia]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/bringing-pain-management-to-africa-spreading-relief-through-training-54188/</guid>
		<description><![CDATA[ALEXANDRIA, Virginia, December 1, 2011  -

Thirty years after the start of the HIV/AIDS epidemic, researchers, health care professionals, philanthropic organizations and others still work tirelessly to bring relief and hope to those affected by the disease.
FHSSA, which began as the Foundation for Hospices in Sub-Saharan Africa, is one such organization working to improve the ... <a href="http://pr.gaeatimes.com/bringing-pain-management-to-africa-spreading-relief-through-training-54188/" title="Bringing Pain Management to Africa: Spreading Relief Through Training">Read more >></a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/bringing-pain-management-to-africa-spreading-relief-through-training-54188/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Mylan Receives Tentative FDA Approval Through PEPFAR for First Heat-Stable, Fixed-Dose Combination of Atazanavir Sulfate and Ritonavir Tablets for HIV/AIDS</title>
		<link>http://pr.gaeatimes.com/mylan-receives-tentative-fda-approval-through-pepfar-for-first-heat-stable-fixed-dose-combination-of-atazanavir-sulfate-and-ritonavir-tablets-for-hivaids-54196/</link>
		<comments>http://pr.gaeatimes.com/mylan-receives-tentative-fda-approval-through-pepfar-for-first-heat-stable-fixed-dose-combination-of-atazanavir-sulfate-and-ritonavir-tablets-for-hivaids-54196/#comments</comments>
		<pubDate>Thu, 01 Dec 2011 05:00:00 +0000</pubDate>
		<dc:creator>Mylan Inc.</dc:creator>
		
		<category><![CDATA[FDA Approval]]></category>

		<category><![CDATA[Government and Policy]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Infectious Disease Control]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[December 1]]></category>

		<category><![CDATA[Mylan Inc.]]></category>

		<category><![CDATA[Pennsylvania]]></category>

		<category><![CDATA[Pittsburgh]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/mylan-receives-tentative-fda-approval-through-pepfar-for-first-heat-stable-fixed-dose-combination-of-atazanavir-sulfate-and-ritonavir-tablets-for-hivaids-54196/</guid>
		<description><![CDATA[PITTSBURGH, December 1, 2011  -


- Product also &#8216;prequalified&#8217; by WHO as a second-line treatment option -
Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Laboratories Limited (formerly Matrix Laboratories Limited) has received tentative approval from the U.S. Food and Drug Administration (FDA) through the President&#8217;s Emergency Plan for AIDS Relief (PEPFAR) for its .... <a href="http://pr.gaeatimes.com/mylan-receives-tentative-fda-approval-through-pepfar-for-first-heat-stable-fixed-dose-combination-of-atazanavir-sulfate-and-ritonavir-tablets-for-hivaids-54196/">Original source &nbsp;: Mylan Receives Tentative FDA Approval Through PEPFAR for First Heat-Stable, Fixed-Dose Combination of Atazanavir Sulfate and Ritonavir Tablets for HIV/AIDS</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/mylan-receives-tentative-fda-approval-through-pepfar-for-first-heat-stable-fixed-dose-combination-of-atazanavir-sulfate-and-ritonavir-tablets-for-hivaids-54196/feed/</wfw:commentRss>
		</item>
		<item>
		<title>&#34;Sitting Ducks&#34; No Longer: Advance Flu Warning Permits Creation of Replikins Custom Synthetic Flu Vaccine in Animals</title>
		<link>http://pr.gaeatimes.com/sitting-ducks-no-longer-advance-flu-warning-permits-creation-of-replikins-custom-synthetic-flu-vaccine-in-animals-53271/</link>
		<comments>http://pr.gaeatimes.com/sitting-ducks-no-longer-advance-flu-warning-permits-creation-of-replikins-custom-synthetic-flu-vaccine-in-animals-53271/#comments</comments>
		<pubDate>Fri, 11 Nov 2011 05:00:00 +0000</pubDate>
		<dc:creator>Bioradar Ltd.</dc:creator>
		
		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Business]]></category>

		<category><![CDATA[Consumer Products]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Infectious Disease Control]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[Pet]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Bioradar Ltd.]]></category>

		<category><![CDATA[London]]></category>

		<category><![CDATA[November 11]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/sitting-ducks-no-longer-advance-flu-warning-permits-creation-of-replikins-custom-synthetic-flu-vaccine-in-animals-53271/</guid>
		<description><![CDATA[LONDON, November 11, 2011  -
- Replikins TransFlu&#8482; Vaccine Now Available for Order from BioRadar UK Ltd.

Animals and humans no longer need to be &#8220;sitting ducks,&#8221; oblivious to and unprepared for emergent infectious disease outbreaks. Rather than being caught off-guard by mass influenza outbreaks, UK-based biotech firm BioRadar Ltd. can successfully analyze the concentration and ... Read more <a href="http://pr.gaeatimes.com/sitting-ducks-no-longer-advance-flu-warning-permits-creation-of-replikins-custom-synthetic-flu-vaccine-in-animals-53271/" title="&quot;Sitting Ducks&quot; No Longer: Advance Flu Warning Permits Creation of Replikins Custom Synthetic Flu Vaccine in Animals">>>></a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/sitting-ducks-no-longer-advance-flu-warning-permits-creation-of-replikins-custom-synthetic-flu-vaccine-in-animals-53271/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Arecor Appoints Dr. Sarah Howell as Chief Operating Officer</title>
		<link>http://pr.gaeatimes.com/arecor-appoints-dr-sarah-howell-as-chief-operating-officer-53198/</link>
		<comments>http://pr.gaeatimes.com/arecor-appoints-dr-sarah-howell-as-chief-operating-officer-53198/#comments</comments>
		<pubDate>Thu, 10 Nov 2011 05:00:00 +0000</pubDate>
		<dc:creator>Arecor</dc:creator>
		
		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Business]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Infectious Disease Control]]></category>

		<category><![CDATA[Personnel Announcements]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Arecor]]></category>

		<category><![CDATA[Cambridge]]></category>

		<category><![CDATA[England]]></category>

		<category><![CDATA[November 10]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/arecor-appoints-dr-sarah-howell-as-chief-operating-officer-53198/</guid>
		<description><![CDATA[CAMBRIDGE, England, November 10, 2011  -

Arecor, the leading company in advancing aqueous formulation solutions for proteins, peptides and vaccines, is pleased to announce the appointment of Dr Sarah Howell as Chief Operating Officer.  Dr Howell will be responsible for the operations of Arecor, with a focus on developing and maintaining Arecor&#8217;s upward growth curve ensuring .... Source &nbsp;: <a href="http://pr.gaeatimes.com/arecor-appoints-dr-sarah-howell-as-chief-operating-officer-53198/" title="Arecor Appoints Dr. Sarah Howell as Chief Operating Officer">Gaea News Network</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/arecor-appoints-dr-sarah-howell-as-chief-operating-officer-53198/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Abbott Honored With Scrip Award for Leadership in Corporate Social Responsibility</title>
		<link>http://pr.gaeatimes.com/abbott-honored-with-scrip-award-for-leadership-in-corporate-social-responsibility-52919/</link>
		<comments>http://pr.gaeatimes.com/abbott-honored-with-scrip-award-for-leadership-in-corporate-social-responsibility-52919/#comments</comments>
		<pubDate>Fri, 04 Nov 2011 05:00:00 +0000</pubDate>
		<dc:creator>Abbott</dc:creator>
		
		<category><![CDATA[Awards]]></category>

		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Business]]></category>

		<category><![CDATA[Corporate Social Responsibility]]></category>

		<category><![CDATA[Government and Policy]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Infectious Disease Control]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Abbott]]></category>

		<category><![CDATA[England]]></category>

		<category><![CDATA[London]]></category>

		<category><![CDATA[November 4]]></category>

		<category><![CDATA[Tanzania]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/abbott-honored-with-scrip-award-for-leadership-in-corporate-social-responsibility-52919/</guid>
		<description><![CDATA[LONDON, November 4, 2011  -

- Award Recognizes Long-Term Results of Partnership to Strengthen Tanzania&#8217;s Health Care System
Scrip, a leading global pharmaceutical and biotech news organisation, honored Abbott and its philanthropic foundation, the Abbott Fund, with a 2011 Scrip Award for Corporate Social Responsibility (CSR) at Scrip&#8217;s seventh annual awards ceremony in London on Thursday ... Original source on Gaea Times at  : <a href="http://pr.gaeatimes.com/abbott-honored-with-scrip-award-for-leadership-in-corporate-social-responsibility-52919/">Abbott Honored With Scrip Award for Leadership in Corporate Social Responsibility</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/abbott-honored-with-scrip-award-for-leadership-in-corporate-social-responsibility-52919/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Quest Diagnostics Announces Launch of Simplexa™ Direct Test for Influenza and Respiratory Viruses in Europe</title>
		<link>http://pr.gaeatimes.com/quest-diagnostics-announces-launch-of-simplexa%e2%84%a2-direct-test-for-influenza-and-respiratory-viruses-in-europe-52883/</link>
		<comments>http://pr.gaeatimes.com/quest-diagnostics-announces-launch-of-simplexa%e2%84%a2-direct-test-for-influenza-and-respiratory-viruses-in-europe-52883/#comments</comments>
		<pubDate>Thu, 03 Nov 2011 05:00:00 +0000</pubDate>
		<dc:creator>Quest Diagnostics Incorporated</dc:creator>
		
		<category><![CDATA[Business]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Infectious Disease Control]]></category>

		<category><![CDATA[Medical Equipment]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[california]]></category>

		<category><![CDATA[California And Madison]]></category>

		<category><![CDATA[Cypress]]></category>

		<category><![CDATA[Europe]]></category>

		<category><![CDATA[Facebook]]></category>

		<category><![CDATA[new jersey]]></category>

		<category><![CDATA[New York]]></category>

		<category><![CDATA[November 3]]></category>

		<category><![CDATA[Quest Diagnostics Incorporated]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/quest-diagnostics-announces-launch-of-simplexa%e2%84%a2-direct-test-for-influenza-and-respiratory-viruses-in-europe-52883/</guid>
		<description><![CDATA[CYPRESS, California and MADISON, New Jersey, November 3, 2011  -

- Focus Diagnostics product eliminates nucleic-acid sample extraction with proprietary technology, for faster testing
Quest Diagnostics Incorporated (NYSE: DGX), the world&#8217;s leading provider of diagnostic testing, information and services, today announced the CE mark and European availability of the Simplexa Flu A/B &#38; RSV Direct test ... <a href="http://pr.gaeatimes.com/quest-diagnostics-announces-launch-of-simplexa%e2%84%a2-direct-test-for-influenza-and-respiratory-viruses-in-europe-52883/">Read : Quest Diagnostics Announces Launch of Simplexa™ Direct Test for Influenza and Respiratory Viruses in Europe</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/quest-diagnostics-announces-launch-of-simplexa%e2%84%a2-direct-test-for-influenza-and-respiratory-viruses-in-europe-52883/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Bill and Melinda Gates Applaud Progress Against Malaria While Urging Renewed Effort</title>
		<link>http://pr.gaeatimes.com/bill-and-melinda-gates-applaud-progress-against-malaria-while-urging-renewed-effort-52051/</link>
		<comments>http://pr.gaeatimes.com/bill-and-melinda-gates-applaud-progress-against-malaria-while-urging-renewed-effort-52051/#comments</comments>
		<pubDate>Tue, 18 Oct 2011 05:00:00 +0000</pubDate>
		<dc:creator>Bill Melinda Gates Foundation</dc:creator>
		
		<category><![CDATA[Corporate Social Responsibility]]></category>

		<category><![CDATA[Foreign Policy / International Affairs]]></category>

		<category><![CDATA[Government and Policy]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Infectious Disease Control]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Bill & Melinda Gates Foundation]]></category>

		<category><![CDATA[October 18]]></category>

		<category><![CDATA[Seattle]]></category>

		<category><![CDATA[Washington]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/bill-and-melinda-gates-applaud-progress-against-malaria-while-urging-renewed-effort-52051/</guid>
		<description><![CDATA[SEATTLE, October 18, 2011  -

 
- Optimism, urgency and innovation needed to bring an end to malaria
Three hundred leading malaria scientists, global health leaders, policymakers, government officials and advocates gathered today at the Malaria Forum to discuss great strides in malaria control and address challenges that are impacting the long-term goal of eradication.
To view the ... Read more <a href="http://pr.gaeatimes.com/bill-and-melinda-gates-applaud-progress-against-malaria-while-urging-renewed-effort-52051/" title="Bill and Melinda Gates Applaud Progress Against Malaria While Urging Renewed Effort">&raquo;&raquo;&raquo;</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/bill-and-melinda-gates-applaud-progress-against-malaria-while-urging-renewed-effort-52051/feed/</wfw:commentRss>
		</item>
		<item>
		<title>African Leaders Malaria Alliance Congratulates President Sirleaf on Nobel Prize Honor</title>
		<link>http://pr.gaeatimes.com/african-leaders-malaria-alliance-congratulates-president-sirleaf-on-nobel-prize-honor-51561/</link>
		<comments>http://pr.gaeatimes.com/african-leaders-malaria-alliance-congratulates-president-sirleaf-on-nobel-prize-honor-51561/#comments</comments>
		<pubDate>Fri, 07 Oct 2011 05:00:00 +0000</pubDate>
		<dc:creator>African Leaders Malaria Alliance</dc:creator>
		
		<category><![CDATA[Children Related]]></category>

		<category><![CDATA[Government and Policy]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Infectious Disease Control]]></category>

		<category><![CDATA[Multicultural]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Public Safety]]></category>

		<category><![CDATA[Africa]]></category>

		<category><![CDATA[African Leaders Malaria Alliance]]></category>

		<category><![CDATA[New York]]></category>

		<category><![CDATA[October 7]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/african-leaders-malaria-alliance-congratulates-president-sirleaf-on-nobel-prize-honor-51561/</guid>
		<description><![CDATA[NEW YORK, October 7, 2011  -

The African Leaders Malaria Alliance (ALMA) Secretariat wishes to congratulate its Deputy Chair, Her Excellency President Ellen Johnson Sirleaf, President of the Republic of Liberia, as well as Ms. Leymah Gbowee and Ms. Tawakkul Karman, on the distinction of being awarded the Nobel Peace Prize for 2011.
President Sirleaf&#8217;s life ... <a href="http://pr.gaeatimes.com/african-leaders-malaria-alliance-congratulates-president-sirleaf-on-nobel-prize-honor-51561/" title="African Leaders Malaria Alliance Congratulates President Sirleaf on Nobel Prize Honor">Read more &raquo;&raquo;</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/african-leaders-malaria-alliance-congratulates-president-sirleaf-on-nobel-prize-honor-51561/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Commonwealth Welcomes Global Commitment to Combat Non-Communicable Diseases</title>
		<link>http://pr.gaeatimes.com/commonwealth-welcomes-global-commitment-to-combat-non-communicable-diseases-50752/</link>
		<comments>http://pr.gaeatimes.com/commonwealth-welcomes-global-commitment-to-combat-non-communicable-diseases-50752/#comments</comments>
		<pubDate>Wed, 21 Sep 2011 05:00:00 +0000</pubDate>
		<dc:creator>The Commonwealth Secretariat</dc:creator>
		
		<category><![CDATA[European Government]]></category>

		<category><![CDATA[Government and Policy]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Infectious Disease Control]]></category>

		<category><![CDATA[Medical Equipment]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[New York]]></category>

		<category><![CDATA[September 21]]></category>

		<category><![CDATA[The Commonwealth Secretariat]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/commonwealth-welcomes-global-commitment-to-combat-non-communicable-diseases-50752/</guid>
		<description><![CDATA[NEW YORK, September 21, 2011  -


- Commonwealth Priorities Captured in Political Declaration of UN High-Level Meeting
The Commonwealth on Wednesday welcomed a political declaration agreed at the United Nations, to galvanise global action against the burden and debilitating impact of Non-Communicable Diseases (NCDs).
The Declaration captured key Commonwealth priorities as identified by Health Ministers at their .... Original source &nbsp;: <a href="http://pr.gaeatimes.com/commonwealth-welcomes-global-commitment-to-combat-non-communicable-diseases-50752/">Commonwealth Welcomes Global Commitment to Combat Non-Communicable Diseases</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/commonwealth-welcomes-global-commitment-to-combat-non-communicable-diseases-50752/feed/</wfw:commentRss>
		</item>
		<item>
		<title>University of Maryland School of Medicine Scientists Identify First Effective Blood-Stage Malaria Vaccine</title>
		<link>http://pr.gaeatimes.com/university-of-maryland-school-of-medicine-scientists-identify-first-effective-blood-stage-malaria-vaccine-50372/</link>
		<comments>http://pr.gaeatimes.com/university-of-maryland-school-of-medicine-scientists-identify-first-effective-blood-stage-malaria-vaccine-50372/#comments</comments>
		<pubDate>Wed, 14 Sep 2011 05:00:00 +0000</pubDate>
		<dc:creator>University Of Maryland School Of Medicine</dc:creator>
		
		<category><![CDATA[Business]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Infectious Disease Control]]></category>

		<category><![CDATA[Media]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Surveys / Polls / Research]]></category>

		<category><![CDATA[Baltimore]]></category>

		<category><![CDATA[Mali]]></category>

		<category><![CDATA[maryland]]></category>

		<category><![CDATA[September 14]]></category>

		<category><![CDATA[University Of Maryland School Of Medicine]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/university-of-maryland-school-of-medicine-scientists-identify-first-effective-blood-stage-malaria-vaccine-50372/</guid>
		<description><![CDATA[BALTIMORE, September 14, 2011  -

- Blood-Stage Vaccine Would Prevent Illness and Transmission of Deadly Disease
Scientists have identified the first effective blood-stage malaria vaccine, according to a New England Journal of Medicine study from University of Maryland School of Medicine researchers, in collaboration with the University of Bamako in Mali, West Africa, and other partners. ... Original source on Gaea Times at  : <a href="http://pr.gaeatimes.com/university-of-maryland-school-of-medicine-scientists-identify-first-effective-blood-stage-malaria-vaccine-50372/">University of Maryland School of Medicine Scientists Identify First Effective Blood-Stage Malaria Vaccine</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/university-of-maryland-school-of-medicine-scientists-identify-first-effective-blood-stage-malaria-vaccine-50372/feed/</wfw:commentRss>
		</item>
		<item>
		<title>TeleTracking Announces Availability of Real-Time Locating System (RTLS) to the UK Health Care Market</title>
		<link>http://pr.gaeatimes.com/teletracking-announces-availability-of-real-time-locating-system-rtls-to-the-uk-health-care-market-50221/</link>
		<comments>http://pr.gaeatimes.com/teletracking-announces-availability-of-real-time-locating-system-rtls-to-the-uk-health-care-market-50221/#comments</comments>
		<pubDate>Tue, 13 Sep 2011 05:00:00 +0000</pubDate>
		<dc:creator>Teletracking Technologies Inc.</dc:creator>
		
		<category><![CDATA[Business]]></category>

		<category><![CDATA[Computer / Electronics]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Infectious Disease Control]]></category>

		<category><![CDATA[Medical Equipment]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[RFID Applications and Tech]]></category>

		<category><![CDATA[Technology]]></category>

		<category><![CDATA[Trade Show]]></category>

		<category><![CDATA[London]]></category>

		<category><![CDATA[September 13]]></category>

		<category><![CDATA[Teletracking Technologies Inc.]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/teletracking-announces-availability-of-real-time-locating-system-rtls-to-the-uk-health-care-market-50221/</guid>
		<description><![CDATA[LONDON, September 13, 2011  -

- On 15th September 2011, TeleTracking will host a symposium demonstrating how patient flow automation and RTLS solutions function in a hospital environment, utilising the ground breaking live testing laboratory at The Health Informatics Research Laboratories, The University of Wales Swansea.
TeleTracking Technologies, Inc. today announced the availability of its next ... Read : <a href="http://pr.gaeatimes.com/teletracking-announces-availability-of-real-time-locating-system-rtls-to-the-uk-health-care-market-50221/">TeleTracking Announces Availability of Real-Time Locating System (RTLS) to the UK Health Care Market</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/teletracking-announces-availability-of-real-time-locating-system-rtls-to-the-uk-health-care-market-50221/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Hyper-Endemic Typhoid in Africa Takes Spotlight at Cannes</title>
		<link>http://pr.gaeatimes.com/hyper-endemic-typhoid-in-africa-takes-spotlight-at-cannes-50308/</link>
		<comments>http://pr.gaeatimes.com/hyper-endemic-typhoid-in-africa-takes-spotlight-at-cannes-50308/#comments</comments>
		<pubDate>Tue, 13 Sep 2011 05:00:00 +0000</pubDate>
		<dc:creator>Sabin Vaccine Institute</dc:creator>
		
		<category><![CDATA[Business]]></category>

		<category><![CDATA[Children Related]]></category>

		<category><![CDATA[Government and Policy]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Infectious Disease Control]]></category>

		<category><![CDATA[Multicultural]]></category>

		<category><![CDATA[Not For Profit]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Surveys / Polls / Research]]></category>

		<category><![CDATA[Africa]]></category>

		<category><![CDATA[Cannes]]></category>

		<category><![CDATA[France]]></category>

		<category><![CDATA[Sabin Vaccine Institute]]></category>

		<category><![CDATA[September 13]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/hyper-endemic-typhoid-in-africa-takes-spotlight-at-cannes-50308/</guid>
		<description><![CDATA[CANNES, France, September 13, 2011  -


- New evidence draws attention to unrecognized burden in the region
Important new evidence revealing hyper-endemic typhoid in Africa will be presented by global health experts and scientists at the 6th International Conference on Vaccines for Enteric Diseases (VED) 2011 on September 14-16 in Cannes, France. The findings, presented by ... <a href="http://pr.gaeatimes.com/hyper-endemic-typhoid-in-africa-takes-spotlight-at-cannes-50308/">Read this article on Gaea Times at  : Hyper-Endemic Typhoid in Africa Takes Spotlight at Cannes</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/hyper-endemic-typhoid-in-africa-takes-spotlight-at-cannes-50308/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Jennewein Biotechnologie and Pfizer Nutrition Collaborate on Human Milk Components</title>
		<link>http://pr.gaeatimes.com/jennewein-biotechnologie-and-pfizer-nutrition-collaborate-on-human-milk-components-49558/</link>
		<comments>http://pr.gaeatimes.com/jennewein-biotechnologie-and-pfizer-nutrition-collaborate-on-human-milk-components-49558/#comments</comments>
		<pubDate>Mon, 29 Aug 2011 05:00:00 +0000</pubDate>
		<dc:creator>Jennewein Biotechnologie Gmbh</dc:creator>
		
		<category><![CDATA[Business]]></category>

		<category><![CDATA[Consumer Products]]></category>

		<category><![CDATA[Contracts]]></category>

		<category><![CDATA[Food / Beverages]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Infectious Disease Control]]></category>

		<category><![CDATA[Investors]]></category>

		<category><![CDATA[Joint Ventures]]></category>

		<category><![CDATA[Multicultural]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Women Related]]></category>

		<category><![CDATA[August 29]]></category>

		<category><![CDATA[Germany]]></category>

		<category><![CDATA[Jennewein Biotechnologie GmbH]]></category>

		<category><![CDATA[Rheinbreitbach]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/jennewein-biotechnologie-and-pfizer-nutrition-collaborate-on-human-milk-components-49558/</guid>
		<description><![CDATA[RHEINBREITBACH, Germany, August 29, 2011  -


- License Agreement Provides Rights to Pfizer Nutrition for Innovative, Biologically-Sourced Human Milk Components
Jennewein Biotechnologie today announced that the company has signed a license agreement with Pfizer Nutrition to develop and market two Human Milk Oligosaccharides (HMOs).  
Human Milk Oligosaccharides represent a major component of mother&#8217;s milk, and provide short and ... <a href="http://pr.gaeatimes.com/jennewein-biotechnologie-and-pfizer-nutrition-collaborate-on-human-milk-components-49558/">Read : Jennewein Biotechnologie and Pfizer Nutrition Collaborate on Human Milk Components</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/jennewein-biotechnologie-and-pfizer-nutrition-collaborate-on-human-milk-components-49558/feed/</wfw:commentRss>
		</item>
		<item>
		<title>2011 Health Conditions for Travel to Mecca (Hajj) Pilgrimage Published</title>
		<link>http://pr.gaeatimes.com/2011-health-conditions-for-travel-to-mecca-hajj-pilgrimage-published-49396/</link>
		<comments>http://pr.gaeatimes.com/2011-health-conditions-for-travel-to-mecca-hajj-pilgrimage-published-49396/#comments</comments>
		<pubDate>Tue, 23 Aug 2011 05:00:00 +0000</pubDate>
		<dc:creator>Elsevier</dc:creator>
		
		<category><![CDATA[Business]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Infectious Disease Control]]></category>

		<category><![CDATA[Media]]></category>

		<category><![CDATA[Multicultural]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Religion]]></category>

		<category><![CDATA[Surveys / Polls / Research]]></category>

		<category><![CDATA[Amman]]></category>

		<category><![CDATA[August 23]]></category>

		<category><![CDATA[Elsevier]]></category>

		<category><![CDATA[Jordan]]></category>

		<category><![CDATA[Saudi Arabia]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/2011-health-conditions-for-travel-to-mecca-hajj-pilgrimage-published-49396/</guid>
		<description><![CDATA[AMMAN, Jordan, August 23, 2011  -

Saudi Ministry of Health issues the entry visa requirements and recommendations for the Hajj and Umra season in 2011
Elsevier, the world&#8217;s leading provider of scientific, technical and medical information products and services, announced today that the Saudi Ministry of Health has published its 2011 health conditions for travelers to .... <a href="http://pr.gaeatimes.com/2011-health-conditions-for-travel-to-mecca-hajj-pilgrimage-published-49396/">Source article on Gaea Times at  &nbsp;: 2011 Health Conditions for Travel to Mecca (Hajj) Pilgrimage Published</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/2011-health-conditions-for-travel-to-mecca-hajj-pilgrimage-published-49396/feed/</wfw:commentRss>
		</item>
		<item>
		<title>The Japan International Cooperation Agency (JICA) and the Bill &amp; Melinda Gates Foundation Announce Partnership on Polio Eradication</title>
		<link>http://pr.gaeatimes.com/the-japan-international-cooperation-agency-jica-and-the-bill-melinda-gates-foundation-announce-partnership-on-polio-eradication-49230/</link>
		<comments>http://pr.gaeatimes.com/the-japan-international-cooperation-agency-jica-and-the-bill-melinda-gates-foundation-announce-partnership-on-polio-eradication-49230/#comments</comments>
		<pubDate>Wed, 17 Aug 2011 05:00:00 +0000</pubDate>
		<dc:creator>Bill Melinda Gates Foundation</dc:creator>
		
		<category><![CDATA[Domestic Policy]]></category>

		<category><![CDATA[Foreign Policy / International Affairs]]></category>

		<category><![CDATA[Government and Policy]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Infectious Disease Control]]></category>

		<category><![CDATA[Investors]]></category>

		<category><![CDATA[Joint Ventures]]></category>

		<category><![CDATA[August 18]]></category>

		<category><![CDATA[Bill & Melinda Gates Foundation]]></category>

		<category><![CDATA[Japan]]></category>

		<category><![CDATA[pakistan]]></category>

		<category><![CDATA[Tokyo]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/the-japan-international-cooperation-agency-jica-and-the-bill-melinda-gates-foundation-announce-partnership-on-polio-eradication-49230/</guid>
		<description><![CDATA[TOKYO, August 18, 2011  -
- 4.9 billion Japanese Yen (JPY) loan from JICA to support polio eradication in Pakistan through 2013

Ms. Sadako Ogata, President of the Japan International Cooperation Agency (JICA), and Mr. Bill Gates, co-chair of the Bill &#38; Melinda Gates Foundation, today announced a strategic partnership to ensure continued progress in the .... <a href="http://pr.gaeatimes.com/the-japan-international-cooperation-agency-jica-and-the-bill-melinda-gates-foundation-announce-partnership-on-polio-eradication-49230/">Source &nbsp;: The Japan International Cooperation Agency (JICA) and the Bill &amp; Melinda Gates Foundation Announce Partnership on Polio Eradication</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/the-japan-international-cooperation-agency-jica-and-the-bill-melinda-gates-foundation-announce-partnership-on-polio-eradication-49230/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Enigma Diagnostics and GSK Announce Collaboration on Assay Development and Commercialization of Enigma&#8217;s ML Platform</title>
		<link>http://pr.gaeatimes.com/enigma-diagnostics-and-gsk-announce-collaboration-on-assay-development-and-commercialization-of-enigmas-ml-platform-48960/</link>
		<comments>http://pr.gaeatimes.com/enigma-diagnostics-and-gsk-announce-collaboration-on-assay-development-and-commercialization-of-enigmas-ml-platform-48960/#comments</comments>
		<pubDate>Wed, 10 Aug 2011 05:00:00 +0000</pubDate>
		<dc:creator>Enigma Diagnostics Limited</dc:creator>
		
		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Infectious Disease Control]]></category>

		<category><![CDATA[Investors]]></category>

		<category><![CDATA[Joint Ventures]]></category>

		<category><![CDATA[Medical Equipment]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[August 10]]></category>

		<category><![CDATA[England]]></category>

		<category><![CDATA[Enigma Diagnostics Limited]]></category>

		<category><![CDATA[London And Oxford]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/enigma-diagnostics-and-gsk-announce-collaboration-on-assay-development-and-commercialization-of-enigmas-ml-platform-48960/</guid>
		<description><![CDATA[LONDON and OXFORD, England, August 10, 2011  -

Enigma Diagnostics Limited (Enigma) and GlaxoSmithKline (GSK) today announced that they have signed agreements for the supply and commercialization on an exclusive basis of the Enigma® ML system in Europe and other designated key countries, including India, Brazil and Russia. The agreements include development by Enigma of .... Original article on Gaea Times at  &nbsp;: <a href="http://pr.gaeatimes.com/enigma-diagnostics-and-gsk-announce-collaboration-on-assay-development-and-commercialization-of-enigmas-ml-platform-48960/">Enigma Diagnostics and GSK Announce Collaboration on Assay Development and Commercialization of Enigma&#8217;s ML Platform</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/enigma-diagnostics-and-gsk-announce-collaboration-on-assay-development-and-commercialization-of-enigmas-ml-platform-48960/feed/</wfw:commentRss>
		</item>
		<item>
		<title>BD and Lab21 Collaborate to Develop Aspergillus Assay for New BD MAX™ Molecular Testing System</title>
		<link>http://pr.gaeatimes.com/bd-and-lab21-collaborate-to-develop-aspergillus-assay-for-new-bd-max%e2%84%a2-molecular-testing-system-48684/</link>
		<comments>http://pr.gaeatimes.com/bd-and-lab21-collaborate-to-develop-aspergillus-assay-for-new-bd-max%e2%84%a2-molecular-testing-system-48684/#comments</comments>
		<pubDate>Wed, 03 Aug 2011 05:00:00 +0000</pubDate>
		<dc:creator>Bd-becton Dickinson</dc:creator>
		
		<category><![CDATA[Business]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Infectious Disease Control]]></category>

		<category><![CDATA[Investors]]></category>

		<category><![CDATA[Joint Ventures]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[August 3]]></category>

		<category><![CDATA[Baltimore And Cambridge]]></category>

		<category><![CDATA[Bd-becton Dickinson]]></category>

		<category><![CDATA[England]]></category>

		<category><![CDATA[maryland]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/bd-and-lab21-collaborate-to-develop-aspergillus-assay-for-new-bd-max%e2%84%a2-molecular-testing-system-48684/</guid>
		<description><![CDATA[BALTIMORE and CAMBRIDGE, England, August 3, 2011  -


- Agreement Marks Significant Planned Addition to System&#8217;s Content-Rich Test Menu

BD Diagnostics, a segment of global medical technology company BD (Becton, Dickinson and Company) (NYSE: BDX), and Lab21, a global leader in personalised healthcare, announced today a collaboration to develop a state-of-the-art molecular diagnostic assay to detect ... <a href="http://pr.gaeatimes.com/bd-and-lab21-collaborate-to-develop-aspergillus-assay-for-new-bd-max%e2%84%a2-molecular-testing-system-48684/" title="BD and Lab21 Collaborate to Develop Aspergillus Assay for New BD MAX™ Molecular Testing System">Read more >></a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/bd-and-lab21-collaborate-to-develop-aspergillus-assay-for-new-bd-max%e2%84%a2-molecular-testing-system-48684/feed/</wfw:commentRss>
		</item>
		<item>
		<title>UM School of Medicine Institute for Genome Sciences Cracks Genomic Code of Deadly German E. coli Outbreak</title>
		<link>http://pr.gaeatimes.com/um-school-of-medicine-institute-for-genome-sciences-cracks-genomic-code-of-deadly-german-e-coli-outbreak-48456/</link>
		<comments>http://pr.gaeatimes.com/um-school-of-medicine-institute-for-genome-sciences-cracks-genomic-code-of-deadly-german-e-coli-outbreak-48456/#comments</comments>
		<pubDate>Wed, 27 Jul 2011 05:00:00 +0000</pubDate>
		<dc:creator>University Of Maryland School Of Medicine</dc:creator>
		
		<category><![CDATA[Clinical Trials / Medical Discoveries]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Infectious Disease Control]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Baltimore]]></category>

		<category><![CDATA[Germany]]></category>

		<category><![CDATA[July 27]]></category>

		<category><![CDATA[maryland]]></category>

		<category><![CDATA[University Of Maryland School Of Medicine]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/um-school-of-medicine-institute-for-genome-sciences-cracks-genomic-code-of-deadly-german-e-coli-outbreak-48456/</guid>
		<description><![CDATA[BALTIMORE, July 27, 2011  -

- Rapid, High Tech Study of Ongoing Epidemic Creates New Paradigm for Outbreak Research
A team led by University of Maryland School of Medicine Institute for Genome Sciences researchers has unraveled the genomic code of the E. coli bacteria that caused the ongoing deadly outbreak in Germany that began in May .... Original article &nbsp;: <a href="http://pr.gaeatimes.com/um-school-of-medicine-institute-for-genome-sciences-cracks-genomic-code-of-deadly-german-e-coli-outbreak-48456/">UM School of Medicine Institute for Genome Sciences Cracks Genomic Code of Deadly German E. coli Outbreak</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/um-school-of-medicine-institute-for-genome-sciences-cracks-genomic-code-of-deadly-german-e-coli-outbreak-48456/feed/</wfw:commentRss>
		</item>
		<item>
		<title>World Hepatitis Alliance Warns that Stigma is a Major Threat to New Initiative Against Hepatitis Epidemic</title>
		<link>http://pr.gaeatimes.com/world-hepatitis-alliance-warns-that-stigma-is-a-major-threat-to-new-initiative-against-hepatitis-epidemic-48459/</link>
		<comments>http://pr.gaeatimes.com/world-hepatitis-alliance-warns-that-stigma-is-a-major-threat-to-new-initiative-against-hepatitis-epidemic-48459/#comments</comments>
		<pubDate>Wed, 27 Jul 2011 05:00:00 +0000</pubDate>
		<dc:creator>World Hepatitis Alliance</dc:creator>
		
		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[European Government]]></category>

		<category><![CDATA[Government and Policy]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Infectious Disease Control]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Geneva]]></category>

		<category><![CDATA[July 27]]></category>

		<category><![CDATA[Switzerland]]></category>

		<category><![CDATA[World Hepatitis Alliance]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/world-hepatitis-alliance-warns-that-stigma-is-a-major-threat-to-new-initiative-against-hepatitis-epidemic-48459/</guid>
		<description><![CDATA[GENEVA, July 27, 2011  -

Patient community calls on governments to do more to reduce stigma as World Hepatitis Day receives official WHO endorsement for the first time
On World Hepatitis Day the World Hepatitis Alliance is warning governments that, unless they also tackle stigma and discrimination, important new action to improve and save millions of .... <a href="http://pr.gaeatimes.com/world-hepatitis-alliance-warns-that-stigma-is-a-major-threat-to-new-initiative-against-hepatitis-epidemic-48459/">Original article &nbsp;: World Hepatitis Alliance Warns that Stigma is a Major Threat to New Initiative Against Hepatitis Epidemic</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/world-hepatitis-alliance-warns-that-stigma-is-a-major-threat-to-new-initiative-against-hepatitis-epidemic-48459/feed/</wfw:commentRss>
		</item>
		<item>
		<title>arGEN-X Announces Non-exclusive License with Biowa for Potelligent® Technology</title>
		<link>http://pr.gaeatimes.com/argen-x-announces-non-exclusive-license-with-biowa-for-potelligent%c2%ae-technology-48380/</link>
		<comments>http://pr.gaeatimes.com/argen-x-announces-non-exclusive-license-with-biowa-for-potelligent%c2%ae-technology-48380/#comments</comments>
		<pubDate>Tue, 26 Jul 2011 05:00:00 +0000</pubDate>
		<dc:creator>Argen-x</dc:creator>
		
		<category><![CDATA[Business]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Infectious Disease Control]]></category>

		<category><![CDATA[Medical Equipment]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[arGEN-X]]></category>

		<category><![CDATA[belgium]]></category>

		<category><![CDATA[Ghent]]></category>

		<category><![CDATA[July 26]]></category>

		<category><![CDATA[Netherlands]]></category>

		<category><![CDATA[new jersey]]></category>

		<category><![CDATA[Princeton]]></category>

		<category><![CDATA[Rotterdam]]></category>

		<category><![CDATA[The Netherlands]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/argen-x-announces-non-exclusive-license-with-biowa-for-potelligent%c2%ae-technology-48380/</guid>
		<description><![CDATA[ROTTERDAM, the Netherlands, GHENT, Belgium, PRINCETON, New Jersey, July 26, 2011  -

 
Synergistic Effect of Applying Potelligent® to Simple Antibodies&#8482; Creates Best-in-class Antibody Therapeutics

arGEN-X, a biopharmaceutical company focused on the discovery and development of human monoclonal antibodies from its proprietary SIMPLE Antibody&#8482; platform, announces it has signed a non-exclusive license agreement with BioWa Inc., the exclusive ... <a href="http://pr.gaeatimes.com/argen-x-announces-non-exclusive-license-with-biowa-for-potelligent%c2%ae-technology-48380/">Read more : arGEN-X Announces Non-exclusive License with Biowa for Potelligent® Technology</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/argen-x-announces-non-exclusive-license-with-biowa-for-potelligent%c2%ae-technology-48380/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Penn Receives $10 Million to Create Center for Orphan Disease Research and Therapy</title>
		<link>http://pr.gaeatimes.com/penn-receives-10-million-to-create-center-for-orphan-disease-research-and-therapy-48412/</link>
		<comments>http://pr.gaeatimes.com/penn-receives-10-million-to-create-center-for-orphan-disease-research-and-therapy-48412/#comments</comments>
		<pubDate>Tue, 26 Jul 2011 05:00:00 +0000</pubDate>
		<dc:creator>The Perelman School Of Medicine At The University Of Pennsylvania</dc:creator>
		
		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Business]]></category>

		<category><![CDATA[Education]]></category>

		<category><![CDATA[Government and Policy]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Higher Education]]></category>

		<category><![CDATA[Infectious Disease Control]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Surveys / Polls / Research]]></category>

		<category><![CDATA[July 26]]></category>

		<category><![CDATA[Pennsylvania]]></category>

		<category><![CDATA[Philadelphia]]></category>

		<category><![CDATA[The Perelman School Of Medicine At The University Of Pennsylvania]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/penn-receives-10-million-to-create-center-for-orphan-disease-research-and-therapy-48412/</guid>
		<description><![CDATA[PHILADELPHIA, July 26, 2011  -

The Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania announces the launching of a first-of-its-kind interdisciplinary center focused on discovering novel treatments for orphan diseases. The Center will bring together, without institutional walls, all necessary approaches to attacking and treating orphan diseases: establishing dedicated research support ... Original source on Gaea Times at  : <a href="http://pr.gaeatimes.com/penn-receives-10-million-to-create-center-for-orphan-disease-research-and-therapy-48412/">Penn Receives $10 Million to Create Center for Orphan Disease Research and Therapy</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/penn-receives-10-million-to-create-center-for-orphan-disease-research-and-therapy-48412/feed/</wfw:commentRss>
		</item>
		<item>
		<title>New Data from SANBS Reinforces 5 Years of Success Preventing HIV and Hepatitis Transmission from Donated Blood</title>
		<link>http://pr.gaeatimes.com/new-data-from-sanbs-reinforces-5-years-of-success-preventing-hiv-and-hepatitis-transmission-from-donated-blood-48320/</link>
		<comments>http://pr.gaeatimes.com/new-data-from-sanbs-reinforces-5-years-of-success-preventing-hiv-and-hepatitis-transmission-from-donated-blood-48320/#comments</comments>
		<pubDate>Mon, 25 Jul 2011 05:00:00 +0000</pubDate>
		<dc:creator>South African National Blood Service</dc:creator>
		
		<category><![CDATA[Clinical Trials / Medical Discoveries]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Infectious Disease Control]]></category>

		<category><![CDATA[Germany]]></category>

		<category><![CDATA[Johannesburg]]></category>

		<category><![CDATA[July 25]]></category>

		<category><![CDATA[South Africa]]></category>

		<category><![CDATA[South African National Blood Service]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/new-data-from-sanbs-reinforces-5-years-of-success-preventing-hiv-and-hepatitis-transmission-from-donated-blood-48320/</guid>
		<description><![CDATA[JOHANNESBURG, July 25, 2011  -

Since 2005, SANBS
Has Eliminated Thousands of Transfusion-Transmittable Infections
from the Blood Supply
The South African National
Blood Service (SANBS) presented new data which demonstrated
that its use of Novartis nucleic acid testing (NAT) products to
screen donated blood for HIV and Hepatitis has resulted in a
significant increase in the safety of the South African blood
supply. ... <a href="http://pr.gaeatimes.com/new-data-from-sanbs-reinforces-5-years-of-success-preventing-hiv-and-hepatitis-transmission-from-donated-blood-48320/" title="New Data from SANBS Reinforces 5 Years of Success Preventing HIV and Hepatitis Transmission from Donated Blood">Read more &raquo;&raquo;</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/new-data-from-sanbs-reinforces-5-years-of-success-preventing-hiv-and-hepatitis-transmission-from-donated-blood-48320/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Cellestis Responds to World Health Organization Guidance on Use of Blood Tests for Active Tuberculosis</title>
		<link>http://pr.gaeatimes.com/cellestis-responds-to-world-health-organization-guidance-on-use-of-blood-tests-for-active-tuberculosis-48321/</link>
		<comments>http://pr.gaeatimes.com/cellestis-responds-to-world-health-organization-guidance-on-use-of-blood-tests-for-active-tuberculosis-48321/#comments</comments>
		<pubDate>Mon, 25 Jul 2011 05:00:00 +0000</pubDate>
		<dc:creator>Cellestis Limited</dc:creator>
		
		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Government and Policy]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Infectious Disease Control]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Public Safety]]></category>

		<category><![CDATA[australia]]></category>

		<category><![CDATA[Cellestis Limited]]></category>

		<category><![CDATA[July 25]]></category>

		<category><![CDATA[Melbourne]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/cellestis-responds-to-world-health-organization-guidance-on-use-of-blood-tests-for-active-tuberculosis-48321/</guid>
		<description><![CDATA[MELBOURNE, Australia, July 25, 2011  -

- Blood Tests Still Necessary for Latent Disease; WHO Guidance is Not Applicable to QuantiFERON-TB Gold (QFT), Used to Test for Latent TB
A new policy recommendation released on 20 July by the World Health Organization (WHO) warns against the use of serological (blood) tests to diagnose active tuberculosis (TB). Serological tests measure .... Source article &nbsp;: <a href="http://pr.gaeatimes.com/cellestis-responds-to-world-health-organization-guidance-on-use-of-blood-tests-for-active-tuberculosis-48321/">Cellestis Responds to World Health Organization Guidance on Use of Blood Tests for Active Tuberculosis</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/cellestis-responds-to-world-health-organization-guidance-on-use-of-blood-tests-for-active-tuberculosis-48321/feed/</wfw:commentRss>
		</item>
		<item>
		<title>INCIVO(R) Receives Positive Opinion From the Committee for Medicinal Products for Human use (CHMP) for the Treatment of Genotype-1 Hepatitis C Virus (HCV)</title>
		<link>http://pr.gaeatimes.com/incivor-receives-positive-opinion-from-the-committee-for-medicinal-products-for-human-use-chmp-for-the-treatment-of-genotype-1-hepatitis-c-virus-hcv-48294/</link>
		<comments>http://pr.gaeatimes.com/incivor-receives-positive-opinion-from-the-committee-for-medicinal-products-for-human-use-chmp-for-the-treatment-of-genotype-1-hepatitis-c-virus-hcv-48294/#comments</comments>
		<pubDate>Fri, 22 Jul 2011 05:00:00 +0000</pubDate>
		<dc:creator>Tibotec Virco-virology Bvba</dc:creator>
		
		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Clinical Trials / Medical Discoveries]]></category>

		<category><![CDATA[FDA Approval]]></category>

		<category><![CDATA[Government and Policy]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Infectious Disease Control]]></category>

		<category><![CDATA[Medical Equipment]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Beerse]]></category>

		<category><![CDATA[belgium]]></category>

		<category><![CDATA[July 22]]></category>

		<category><![CDATA[Tibotec Virco-virology Bvba]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/incivor-receives-positive-opinion-from-the-committee-for-medicinal-products-for-human-use-chmp-for-the-treatment-of-genotype-1-hepatitis-c-virus-hcv-48294/</guid>
		<description><![CDATA[BEERSE, Belgium, July 22, 2011  -

 
- Expanding New Treatment Class for Patients With HCV
-
Tibotec Virco-Virology BVBA, one of the Janssen Pharmaceutical
Companies, announced today that the Committee for Medicinal
Products for Human Use (CHMP) of the European Medicines Agency
(EMA) adopted a positive opinion recommending the approval of
INCIVO (telaprevir), a direct acting antiviral (DAA) for the
treatment of .... <a href="http://pr.gaeatimes.com/incivor-receives-positive-opinion-from-the-committee-for-medicinal-products-for-human-use-chmp-for-the-treatment-of-genotype-1-hepatitis-c-virus-hcv-48294/">Original article on Gaea Times at  &nbsp;: INCIVO(R) Receives Positive Opinion From the Committee for Medicinal Products for Human use (CHMP) for the Treatment of Genotype-1 Hepatitis C Virus (HCV)</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/incivor-receives-positive-opinion-from-the-committee-for-medicinal-products-for-human-use-chmp-for-the-treatment-of-genotype-1-hepatitis-c-virus-hcv-48294/feed/</wfw:commentRss>
		</item>
		<item>
		<title>AMP and WHO Receive Grant to Strengthen Health Logistics in sub-Saharan Africa</title>
		<link>http://pr.gaeatimes.com/amp-and-who-receive-grant-to-strengthen-health-logistics-in-sub-saharan-africa-48238/</link>
		<comments>http://pr.gaeatimes.com/amp-and-who-receive-grant-to-strengthen-health-logistics-in-sub-saharan-africa-48238/#comments</comments>
		<pubDate>Thu, 21 Jul 2011 05:00:00 +0000</pubDate>
		<dc:creator>Agence De Medecine Preventive amp</dc:creator>
		
		<category><![CDATA[Banking and Financial Services]]></category>

		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Financing Agreements]]></category>

		<category><![CDATA[Government and Policy]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Infectious Disease Control]]></category>

		<category><![CDATA[Not For Profit]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Africa]]></category>

		<category><![CDATA[Agence De Medecine Preventive (amp)]]></category>

		<category><![CDATA[France]]></category>

		<category><![CDATA[July 21]]></category>

		<category><![CDATA[Paris And Geneva]]></category>

		<category><![CDATA[Switzerland]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/amp-and-who-receive-grant-to-strengthen-health-logistics-in-sub-saharan-africa-48238/</guid>
		<description><![CDATA[PARIS and GENEVA, July 21, 2011  -


 
The Agence de Médecine Préventive (AMP) and the World Health
Organization (WHO) have received two grants totaling US$6 million
from the Bill &#38; Melinda Gates Foundation to provide technical
support to increase the capacity and competence of health
logisticians in sub-Saharan Africa.
The project, called &#8220;LOGIVAC&#8221;, will establish two regional
health logistics reference centers .... <a href="http://pr.gaeatimes.com/amp-and-who-receive-grant-to-strengthen-health-logistics-in-sub-saharan-africa-48238/">Original article &nbsp;: AMP and WHO Receive Grant to Strengthen Health Logistics in sub-Saharan Africa</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/amp-and-who-receive-grant-to-strengthen-health-logistics-in-sub-saharan-africa-48238/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Gates Foundation Launches Effort to Reinvent the Toilet</title>
		<link>http://pr.gaeatimes.com/gates-foundation-launches-effort-to-reinvent-the-toilet-48133/</link>
		<comments>http://pr.gaeatimes.com/gates-foundation-launches-effort-to-reinvent-the-toilet-48133/#comments</comments>
		<pubDate>Tue, 19 Jul 2011 05:00:00 +0000</pubDate>
		<dc:creator>Bill Melinda Gates Foundation</dc:creator>
		
		<category><![CDATA[Business]]></category>

		<category><![CDATA[Government and Policy]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Infectious Disease Control]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[Not For Profit]]></category>

		<category><![CDATA[Africa]]></category>

		<category><![CDATA[Bill & Melinda Gates Foundation]]></category>

		<category><![CDATA[Facebook]]></category>

		<category><![CDATA[July 19]]></category>

		<category><![CDATA[Kigali]]></category>

		<category><![CDATA[Rwanda]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/gates-foundation-launches-effort-to-reinvent-the-toilet-48133/</guid>
		<description><![CDATA[KIGALI, Rwanda, July 19, 2011  -

New Strategy
Promotes Adoption of Safe, Affordable Sanitation in the Developing
World
The Bill &#38; Melinda Gates Foundation today announced the
launch of a strategy to help bring safe, clean, sanitation services
to millions of poor people in the developing world.
In a keynote address at the 2011 AfricaSan Conference in Kigali,
Sylvia Mathews Burwell, president ... <a href="http://pr.gaeatimes.com/gates-foundation-launches-effort-to-reinvent-the-toilet-48133/">Read more : Gates Foundation Launches Effort to Reinvent the Toilet</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/gates-foundation-launches-effort-to-reinvent-the-toilet-48133/feed/</wfw:commentRss>
		</item>
		<item>
		<title>RAM Helps Keep Meningitis Cyclists on Track</title>
		<link>http://pr.gaeatimes.com/ram-helps-keep-meningitis-cyclists-on-track-47982/</link>
		<comments>http://pr.gaeatimes.com/ram-helps-keep-meningitis-cyclists-on-track-47982/#comments</comments>
		<pubDate>Fri, 15 Jul 2011 05:00:00 +0000</pubDate>
		<dc:creator>Remote Asset Management ram</dc:creator>
		
		<category><![CDATA[Auto]]></category>

		<category><![CDATA[Auto and Transportation]]></category>

		<category><![CDATA[Business]]></category>

		<category><![CDATA[Computer / Electronics]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Infectious Disease Control]]></category>

		<category><![CDATA[Licensing / Marketing Agreements]]></category>

		<category><![CDATA[Sporting Events]]></category>

		<category><![CDATA[Sports]]></category>

		<category><![CDATA[Sports Equipment and Accessories]]></category>

		<category><![CDATA[Technology]]></category>

		<category><![CDATA[Wireless Communications]]></category>

		<category><![CDATA[England]]></category>

		<category><![CDATA[France]]></category>

		<category><![CDATA[July 15]]></category>

		<category><![CDATA[Leeds]]></category>

		<category><![CDATA[Remote Asset Management (ram)]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/ram-helps-keep-meningitis-cyclists-on-track-47982/</guid>
		<description><![CDATA[LEEDS, England, July 15, 2011  -

 
Four cyclists from Leeds have successfully completed their
marathon charity ride from the champagne bar Epernay in Leeds city
centre to the French town of Epernay with the help of a generous
donation from Remote Asset
Management (RAM).
Leeds-based vehicle tracking company RAM donated its award
winning technology to the team of ambitious fundraisers.
The 7 .... <a href="http://pr.gaeatimes.com/ram-helps-keep-meningitis-cyclists-on-track-47982/">Original source &nbsp;: RAM Helps Keep Meningitis Cyclists on Track</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/ram-helps-keep-meningitis-cyclists-on-track-47982/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Sabin Vaccine Institute Announces the Election of Four New Members to Board of Trustees</title>
		<link>http://pr.gaeatimes.com/sabin-vaccine-institute-announces-the-election-of-four-new-members-to-board-of-trustees-47929/</link>
		<comments>http://pr.gaeatimes.com/sabin-vaccine-institute-announces-the-election-of-four-new-members-to-board-of-trustees-47929/#comments</comments>
		<pubDate>Thu, 14 Jul 2011 05:00:00 +0000</pubDate>
		<dc:creator>Sabin Vaccine Institute</dc:creator>
		
		<category><![CDATA[Business]]></category>

		<category><![CDATA[Government and Policy]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Infectious Disease Control]]></category>

		<category><![CDATA[Not For Profit]]></category>

		<category><![CDATA[Personnel Announcements]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[District of Columbia]]></category>

		<category><![CDATA[July 14]]></category>

		<category><![CDATA[Sabin Vaccine Institute]]></category>

		<category><![CDATA[Washington]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/sabin-vaccine-institute-announces-the-election-of-four-new-members-to-board-of-trustees-47929/</guid>
		<description><![CDATA[WASHINGTON, July 14, 2011  -

The Sabin Vaccine Institute (Sabin) is pleased to announce the
election of Baroness Helene Hayman, Gary Rosenthal, Marc Shapiro,
and Alisa Swidler to the organization&#8217;s Board of Trustees.
&#8220;We are honored to have such distinguished individuals join the
Sabin Board,&#8221; said Morton Hyman, Chairman of the Board of Trustees.
&#8220;We appreciate their trust and confidence .... Source &nbsp;: <a href="http://pr.gaeatimes.com/sabin-vaccine-institute-announces-the-election-of-four-new-members-to-board-of-trustees-47929/" title="Sabin Vaccine Institute Announces the Election of Four New Members to Board of Trustees">Gaea News Network</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/sabin-vaccine-institute-announces-the-election-of-four-new-members-to-board-of-trustees-47929/feed/</wfw:commentRss>
		</item>
	</channel>
</rss>

